Medicine & Life Sciences
Fabry Disease
100%
Mucopolysaccharidoses
75%
Globoid Cell Leukodystrophy
63%
Glycogen Storage Disease Type II
62%
Neuronal Ceroid-Lipofuscinoses
59%
Patient Advocacy
53%
GM1 Gangliosidosis
51%
Gangliosidoses
49%
Mucolipidoses
46%
Rare Diseases
39%
Therapeutics
38%
Neonatal Screening
38%
Longitudinal Studies
35%
Research Personnel
35%
Bone Diseases
34%
Central Nervous System Diseases
33%
Lysosomes
33%
Immunologic Factors
33%
Mucopolysaccharidosis IV
32%
Undiagnosed Diseases
31%
Natural History
31%
Publications
23%
Kidney
23%
Central Nervous System
22%
Biomarkers
21%
Wolman Disease
18%
GM2 Gangliosidosis
17%
Parturition
17%
Molecular Biology
16%
Inheritance Patterns
15%
Pathology
15%
Catalogs
15%
Gene Editing
15%
Immune Tolerance
14%
Clinical Trials
14%
Drug Therapy
14%
Statistical Models
13%
Mutation
13%
Glycosaminoglycans
13%
Live Birth
12%
Foster Home Care
12%
Neurologic Manifestations
12%
Morbidity
12%
Population
12%
Lipid Metabolism
11%
Age of Onset
11%
Genetic Therapy
11%
Glycoproteins
10%
Biomedical Research
10%
Disease Management
10%
Genes
9%
Newborn Infant
9%
Industry
9%
Stem Cells
9%
Genetic Association Studies
8%
Disease Progression
8%
Health Care Outcome Assessment
8%
Transplants
7%
Phenotype
7%
Enzymes
6%
Physicians
6%
Education
6%
Incidence
5%
Lung
5%